|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Sage Therapeutics (NASDAQ: SAGE) through any online brokerage.
The latest price target for Sage Therapeutics (NASDAQ: SAGE) was reported by Canaccord Genuity on July 27, 2021. The analyst firm set a price target for 96.00 expecting SAGE to rise to within 12 months (a possible 114.14% upside). 25 analyst firms have reported ratings in the last year.
The stock price for Sage Therapeutics (NASDAQ: SAGE) is $44.83 last updated Today at 7:18:24 PM.
There are no upcoming dividends for Sage Therapeutics.
There is no upcoming split for Sage Therapeutics.
Sage Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.